Search Results | Pediatrics | American Academy of Pediatrics

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Management of Pediatric Lyme Disease: Updates From 2020 Lyme Guidelines

H. Cody Meissner, MD, Allen C. Steere, MD

Pediatrics (2022) 149 (3): e2021054980.

Published: February 2022

View article

Journal Articles

The Importance of MMR Immunization in the United States

Olivia Perrone, MD, H. Cody Meissner, MD

Pediatrics (2020) 146 (2): e20200251.

Published: August 2020

View article

Journal Articles

From Peyton Rous to the HPV Vaccine: A Journey of Discovery and Progress

H. Cody Meissner, MD

Pediatrics (2019) 144 (6): e20192345.

Published: December 2019

View article

Journal Articles

Understanding FDA-Approved Labeling and CDC Recommendations for Use of Vaccines

H. Cody Meissner, MD, Karen Farizo, MD, Douglas Pratt, MD, Larry K. Pickering, MD, Amanda C. Cohn, MD

Pediatrics (2018) 142 (3): e20180780.

Published: September 2018

View article

Journal Articles

Authors’ Responses In Response to the Letter From Ambrose

H. Cody Meissner, MD, Michael T. Brady, MD, Carrie L. Byington, MD, David W. Kimberlin, MD, Alan S. Lieberthal, MD ...

Pediatrics (2014) 134 (6): e1782–e1783.

Published: December 2014

View article

Journal Articles

Clinical Practice Guideline: The Diagnosis, Management, and Prevention of Bronchiolitis

Shawn L. Ralston, MD, Allan S. Lieberthal, MD, H. Cody Meissner, MD, Brian K. Alverson, MD, Jill E. Baley, MD ...

Pediatrics (2014) 134 (5): e1474–e1502.

Published: November 2014

View article

Journal Articles

Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection

COMMITTEE ON INFECTIOUS DISEASES AND BRONCHIOLITIS GUIDELINES COMMITTEE, Michael T. Brady, MD, Carrie L. Byington, MD, H. Dele Davies, MD, Kathryn M. Edwards, MD ...

Pediatrics (2014) 134 (2): 415–420.

Published: August 2014

View article

Journal Articles

Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection

COMMITTEE ON INFECTIOUS DISEASES and BRONCHIOLITIS GUIDELINES COMMITTEE, Michael T. Brady, MD, Carrie L. Byington, MD, H. Dele Davies, MD, Kathryn M. Edwards, MD ...

Pediatrics (2014) 134 (2): e620–e638.

Published: August 2014

View article

Journal Articles

Authors’ Response Re: Clarifying Costs and Benefits of Respiratory Syncytial Virus Immunoprophylaxis

H. Cody Meissner, MD, David W. Kimberlin, MD

Pediatrics (2014) 133 (4): e1101–e1103.

Published: April 2014

View article

Journal Articles

RSV Immunoprophylaxis: Does the Benefit Justify the Cost?

H. Cody Meissner, MD, David W. Kimberlin, MD

Pediatrics (2013) 132 (5): 915–918.

Published: November 2013

View article

Journal Articles

A Randomized Study of a Monoclonal Antibody (Pagibaximab) to Prevent Staphylococcal Sepsis

Leonard E. Weisman, MD, Helen M. Thackray, MD, Robin H. Steinhorn, MD, William F. Walsh, MD, Herbert A. Lassiter, MD ...

Pediatrics (2011) 128 (2): 271–279.

Published: August 2011

View article

Journal Articles

The Role of Immunoprophylaxis in the Reduction of Disease Attributable to Respiratory Syncytial Virus

H. Cody Meissner, MD, Joseph A. Bocchini, Jr, MD, Michael T. Brady, MD, Caroline B. Hall, MD, David W. Kimberlin, MD ...

Pediatrics (2009) 124 (6): 1676–1679.

Published: December 2009

View article

Journal Articles

Varicella Prevention in the United States: A Review of Successes and Challenges

Mona Marin, MD, H. Cody Meissner, MD, Jane F. Seward, MBBS, MPH

Pediatrics (2008) 122 (3): e744–e751.

Published: September 2008

View article

Journal Articles

Elimination of Rubella From the United States: A Milestone on the Road to Global Elimination

H. Cody Meissner, MD, Susan E. Reef, MD, Stephen Cochi, MD, MPH

Pediatrics (2006) 117 (3): 933–935.

Published: March 2006

View article

Journal Articles

Annual Variation in Respiratory Syncytial Virus Season and Decisions Regarding Immunoprophylaxis With Palivizumab

H. Cody Meissner, MD, Larry J. Anderson, MD, Larry K. Pickering, MD

Pediatrics (2004) 114 (4): 1082–1084.

Published: October 2004

View article

Journal Articles

Measles Vaccines and the Potential for Worldwide Eradication of Measles

H. Cody Meissner, MD, Peter M. Strebel, MD, Walter A. Orenstein, MD

Pediatrics (2004) 114 (4): 1065–1069.

Published: October 2004

View article

Journal Articles

Unpredictable Patterns of Viral Respiratory Disease in Children

H. Cody Meissner, MD, Margaret B. Rennels, MD

Pediatrics (2004) 113 (6): 1814–1816.

Published: June 2004

View article

Journal Articles

Immunoprophylaxis With RespiGam

H. Cody Meissner, MD, Margaret B. Rennels, MD, Sarah S. Long, MD, Larry K. Pickering, MD

Pediatrics (2004) 113 (3): 629.

Published: March 2004

View article

Journal Articles

Revised Indications for the Use of Palivizumab and Respiratory Syncytial Virus Immune Globulin Intravenous for the Prevention of Respiratory Syncytial Virus Infections

H. Cody Meissner, MD, Sarah S. Long, MD, Committee on Infectious Diseases, and Committee on Fetus and Newborn

Pediatrics (2003) 112 (6): 1447–1452.

Published: December 2003

View article

Includes: Supplementary data

Journal Articles

Kawasaki Syndrome: Where Are the Answers?

H. Cody Meissner, MD, Donald Y. M. Leung, MD, PhD

Pediatrics (2003) 112 (3): 672–676.

Published: September 2003

View article

NARROW

Management of Pediatric Lyme Disease: Updates From 2020 Lyme Guidelines

The Importance of MMR Immunization in the United States

From Peyton Rous to the HPV Vaccine: A Journey of Discovery and Progress

Understanding FDA-Approved Labeling and CDC Recommendations for Use of Vaccines

Authors’ Responses In Response to the Letter From Ambrose

Clinical Practice Guideline: The Diagnosis, Management, and Prevention of Bronchiolitis

Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection

Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection

Authors’ Response Re: Clarifying Costs and Benefits of Respiratory Syncytial Virus Immunoprophylaxis

RSV Immunoprophylaxis: Does the Benefit Justify the Cost?

A Randomized Study of a Monoclonal Antibody (Pagibaximab) to Prevent Staphylococcal Sepsis

The Role of Immunoprophylaxis in the Reduction of Disease Attributable to Respiratory Syncytial Virus

Varicella Prevention in the United States: A Review of Successes and Challenges

Elimination of Rubella From the United States: A Milestone on the Road to Global Elimination

Annual Variation in Respiratory Syncytial Virus Season and Decisions Regarding Immunoprophylaxis With Palivizumab

Measles Vaccines and the Potential for Worldwide Eradication of Measles

Unpredictable Patterns of Viral Respiratory Disease in Children

Immunoprophylaxis With RespiGam

Revised Indications for the Use of Palivizumab and Respiratory Syncytial Virus Immune Globulin Intravenous for the Prevention of Respiratory Syncytial Virus Infections

Kawasaki Syndrome: Where Are the Answers?

Email alerts

Journals

Policy

Books

News

Solutions

Institutions/Librarians

Group Practices

Licensing/Permissions

Integrations

Advertising

Email alerts

Journals

News

Solutions

This Feature Is Available To Subscribers Only